Home
MRKR
MRKR News

Latest Marker Therapeutics Inc. (MRKR) News on June 6, 2025

Marker Therapeutics Reports that Lymphodepletion Improves the Expansion and Persistence of Multi-Antigen Recognizing T Cells in Patients with Lymphoma

GlobeNewswire

17 days ago

Marker Therapeutics Reports that Lymphodepletion Improves the Expansion and Persistence of Multi-Antigen Recognizing T Cells in Patients with Lymphoma

GlobeNewswire

18 days ago

Marker Therapeutics to Spotlight Multi-Antigen Recognizing (MAR)-T Cells in High-Profile Panel on CAR-T Cell Therapies

Marker Therapeutics Full Year 2024 Earnings: Misses Expectations

Simply Wall St.

2 months ago

Marker Therapeutics Full Year 2024 Earnings: Misses Expectations

Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference

GlobeNewswire

2 months ago

Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference

Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results

GlobeNewswire

2 months ago

Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

GlobeNewswire

3 months ago

Marker Therapeutics to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 12/27/2024

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 12/26/2024

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 12/24/2024

MT Newswires

6 months ago

Marker Therapeutics to Raise $16.1 Million in Private Placement

Marker Therapeutics Announces $16.1 Million Private Placement

GlobeNewswire

6 months ago

Marker Therapeutics Announces $16.1 Million Private Placement

Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma

GlobeNewswire

6 months ago

Marker Therapeutics Provides a Clinical Update on MT-601 in Patients with Lymphoma

Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer

GlobeNewswire

6 months ago

Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer

Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium

GlobeNewswire

6 months ago

Marker Therapeutics to Present at the 2024 Ladenburg Thalmann & Co. Virtual Oncology Innovators and Investors Symposium

Marker Therapeutics Leads 3 Noteworthy US Penny Stocks

Simply Wall St.

6 months ago

Marker Therapeutics Leads 3 Noteworthy US Penny Stocks

MT Newswires

6 months ago

Marker Therapeutics Files $300 Million Mixed Shelf

Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit

GlobeNewswire

6 months ago

Marker Therapeutics to Present at the Citizens JMP Hematology and Oncology Summit

Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

7 months ago

Marker Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire

7 months ago

Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

US Penny Stocks To Consider In October 2024

Simply Wall St.

7 months ago

US Penny Stocks To Consider In October 2024

TipRanks

7 months ago

Marker Therapeutics price target raised to $19 from $11 at Ladenburg

AML cell therapy trials to watch in 2024 targeting GvHD

Clinical Trials Arena

8 months ago

AML cell therapy trials to watch in 2024 targeting GvHD

Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors

GlobeNewswire

9 months ago

Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors

Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire

10 months ago

Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

MT Newswires

10 months ago

Marker Therapeutics Gets $2 Million Grant From National Institutes of Health

Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma

GlobeNewswire

10 months ago

Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma

Marker Therapeutics (NASDAQ:MRKR) shareholders are up 20% this past week, but still in the red over the last five years

Simply Wall St.

a year ago

Marker Therapeutics (NASDAQ:MRKR) shareholders are up 20% this past week, but still in the red over the last five years

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares

GuruFocus.com

a year ago

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares

GuruFocus.com

a year ago

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares

Gluckstein Lawyers Involved in Landmark Ruling Against Ukraine International Airlines in Flight PS 752 Case

CNW Group

a year ago

Gluckstein Lawyers Involved in Landmark Ruling Against Ukraine International Airlines in Flight PS 752 Case

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire

a year ago

Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies

GlobeNewswire

a year ago

Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies

Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results

GlobeNewswire

a year ago

Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results

Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

GlobeNewswire

a year ago

Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class

PR Newswire

a year ago

IceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master Class

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 01/26/2024

Strength Seen in Modiv Industrial, Inc. (MDV): Can Its 7.1% Jump Turn into More Strength?

Zacks

a year ago

Strength Seen in Modiv Industrial, Inc. (MDV): Can Its 7.1% Jump Turn into More Strength?

Semiconductor Manufacturing Stocks Q3 Highlights: Kulicke and Soffa (NASDAQ:KLIC)

StockStory

a year ago

Semiconductor Manufacturing Stocks Q3 Highlights: Kulicke and Soffa (NASDAQ:KLIC)

AXT, Inc. Schedules Fourth Quarter 2023 Earnings Release for Feb. 22, 2024

GlobeNewswire

a year ago

AXT, Inc. Schedules Fourth Quarter 2023 Earnings Release for Feb. 22, 2024

Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601

GlobeNewswire

a year ago

Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601

3 Stocks With the Best Shot to 10X by 2025

InvestorPlace

a year ago

3 Stocks With the Best Shot to 10X by 2025

Is Allakos (ALLK) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Allakos (ALLK) Stock Outpacing Its Medical Peers This Year?

IceCure Medical's ProSense® Featured at Indian Society of Vascular and Interventional Radiology Conference: Key Opinion Leaders Highlight Benefits of Cryoablation

PR Newswire

a year ago

IceCure Medical's ProSense® Featured at Indian Society of Vascular and Interventional Radiology Conference: Key Opinion Leaders Highlight Benefits of Cryoablation

Grove Collaborative Surpasses 15 Million Pounds of Nature-Bound Single-Use Plastic Collected Through Plastic Neutrality Commitment & Partnerships

Business Wire

a year ago

Grove Collaborative Surpasses 15 Million Pounds of Nature-Bound Single-Use Plastic Collected Through Plastic Neutrality Commitment & Partnerships

Semantix Announces CFO Resignation and Succession Plan

GlobeNewswire

a year ago

Semantix Announces CFO Resignation and Succession Plan

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Benzinga

a year ago

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization

GlobeNewswire

a year ago

Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization

Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones

PR Newswire

a year ago

Elevation Oncology Announces Program Updates and Upcoming 2024 Milestones

Business Wire

a year ago

High Income Securities Fund Announces Monthly Distributions For First Quarter of 2024

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update

PR Newswire

a year ago

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

The Fly

a year ago

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”

GlobeNewswire

a year ago

Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”

JOHN HANCOCK TAX-ADVANTAGED GLOBAL SHAREHOLDER YIELD FUND ANNOUNCE PROPOSED MERGER

PR Newswire

a year ago

JOHN HANCOCK TAX-ADVANTAGED GLOBAL SHAREHOLDER YIELD FUND ANNOUNCE PROPOSED MERGER

5E Advanced Materials to Hold Stockholder Call December 19, 2023

GlobeNewswire

a year ago

5E Advanced Materials to Hold Stockholder Call December 19, 2023

Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse

GlobeNewswire

a year ago

Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse

Business Wire

a year ago

Phunware Announces Pricing of $2.8 Million Public Offering

New Strong Buy Stocks for December 7th

Zacks

a year ago

New Strong Buy Stocks for December 7th

Phunware Launches Proposed Public Offering of Securities

GlobeNewswire

2 years ago

Phunware Launches Proposed Public Offering of Securities

Business Wire

2 years ago

High Income Securities Fund Announces Adjournment of Annual Stockholder Meeting

Thomson Reuters StreetEvents

2 years ago

Q3 2023 NIU Technologies Earnings Call

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2023 Earnings Call Transcript

Identiv Wins 2023 Security Vanguard Award for Innovation in Community Security

Business Wire

2 years ago

Identiv Wins 2023 Security Vanguard Award for Innovation in Community Security

Identiv Sets Fourth Quarter 2023 Investor Conference Schedule

Business Wire

2 years ago

Identiv Sets Fourth Quarter 2023 Investor Conference Schedule

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

GlobeNewswire

2 years ago

NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements

Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

GlobeNewswire

2 years ago

Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Via Renewables Inc (VIA) Reports $14.7 Million Net Income for Q3 2023

GuruFocus.com

2 years ago

Via Renewables Inc (VIA) Reports $14.7 Million Net Income for Q3 2023

Allot to Release Third Quarter 2023 Earnings and Host Conference Call on November 16, 2023

GlobeNewswire

2 years ago

Allot to Release Third Quarter 2023 Earnings and Host Conference Call on November 16, 2023

Eagle Point Income Company Inc. Schedules Release of Third Quarter 2023 Financial Results on Tuesday, November 14, 2023

Business Wire

2 years ago

Eagle Point Income Company Inc. Schedules Release of Third Quarter 2023 Financial Results on Tuesday, November 14, 2023

BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M.S.Q. Ventures

CNW Group

2 years ago

BioLineRx entered Exclusive License Agreement to Motixafortide in Asia, advisored by M.S.Q. Ventures

Share on Social Networks: